Niki BioSolutions, Inc. SEC filings NIKI

Niki BioSolutions, Inc. has 258 filings in SEC EDGAR's recent list, going back to Mar 28, 2018. Its latest annual report, Form 20-F, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
20-F Annual report (foreign issuer) Mar 27, 2026 Dec 31, 2025
20-F Annual report (foreign issuer) Apr 30, 2025 Dec 31, 2024
20-F Annual report (foreign issuer) Apr 30, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) Apr 28, 2023 Dec 31, 2022
20-F/A Amended annual report (foreign issuer) Jan 17, 2023 Dec 31, 2021
20-F Annual report (foreign issuer) Apr 29, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Apr 19, 2021 Dec 31, 2020
20-F Annual report (foreign issuer) Apr 29, 2020 Dec 31, 2019
20-F/A Amended annual report (foreign issuer) Apr 22, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Apr 15, 2019 Dec 31, 2018

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Measuring & Controlling Devices, NEC (SIC 3829)
Listed as
NIKI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Princeton, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1734005
Former names
Aptorum Group Ltd (until Jun 22, 2026)

Other Measuring & Controlling Devices, NEC companies

All 11 Measuring & Controlling Devices, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.